Completed NA INTERVENTIONAL 2-arm NCT06620640

A Study Evaluating the Efficiency and Safety for the VGuard Device in Alzheimer's Disease. (CogniGuard)

A Randomized, Double-blind, Experimental Study Evaluating the Efficiency and Safety for the VGuard Device in the Treatment of Alzheimer's Disease.

Sponsor: Neuromedical Sp. z o.o.

Conditions Alzheimer Disease (AD)

Interventions Intervention will most probably modify activity of neuron networks in specific brain areas responsible for cognitive functions, especially memory consolidation.

Updated 2 times since 2024 Last updated: Sep 27, 2024 Started: Jan 21, 2021 Primary completion: Dec 31, 2021 Completion: Dec 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Alzheimer Disease (AD) and is currently completed. Neuromedical Sp. z o.o. leads this study, which shows 2 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

2 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Oct 2024 — Sep 2025 [monthly]

Completed NA

First recorded

Jan 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Neuromedical Sp. z o.o.

Data source: Neuromedical Sp. z o.o.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lodz, Poland